Zarei I, Koistinen V.M, Kokla M, Klåvus A, Babu A.F*, Lehtonen M, Auriola S, and Hanhineva K*. (2022). Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition. Sci Rep. 12:15018. DOI

Jia W*, Panagiotou G*. (2022). Recent advances in diabetes and microbiota. Science Bulletin. 67(17):1720-1723. DOI

Garcia-Morena D*, Lok J*, Lopez-Escalera S*, Fernandez-Cantos M.V*, Babu A*, Aranzamendi C, El Aidy S, Hanhineva K*, El-Nezamy H*, Kuipers O.P* and Wellejus A*. (2022). Can microbiota modulation prevent the development of fatty liver disease? Project Repository Journal. 14:pp.66-69. DOI

Lopez-Escalera S*, Wellejus A*. (2022). Evaluation of Caco-2 and human intestinal epithelial cells as in vitro models of colonic and small intestinal integrity. Biochemistry and Biophysics Reports. 31:101314. DOI

Leung H*, Long X, Ni Y, Qian L, Nychas E*, Leal Siliceo S*, Pohl D*, Hanhineva K*, Liu Y, Xu A*, Nielsen HB*, Belda E, Clément K, Loomba R, Li H, Jia W*, Panagiotou G*. (2022). Risk assessment with gut microbiome and metabolite markers in NAFLD development. Sci Transl Med. 14(648):eabk0855. DOI

Hedin KA*, Rees VE, Zhang H, Vibeke Kruse, Vazquez-Uribe R, Sommer M*. (2022). Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract. Sci Rep.12:8862. DOI

Babu AF*, Csader S*, Männistö V, Tauriainen MM, Pentikäinen H, Savonen K, Klåvus A, Koistinen V, Hanhineva K*, Schwab U* (2022). Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool. Sci Rep.12(1):6485. DOI

Babu AF*, Koistinen VM, Turunen S, Solano-Aguilar G, Urban JF Jr., Zarei I, Hanhineva K* (2022). Identification and Distribution of Sterols, Bile Acids, and Acylcarnitines by LC-MS/MS in Humans, Mice, and Pigs-A Qualitative Analysis. Metabolites. 12(1):49. DOI


Babu AF*, Csader S*, Lok J*, Gómez-Gallego C, Hanhineva K*, El-Nezami H*, Schwab U* (2021). Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis. Nutrients 13(9):3135. DOI

Fernandez-Cantos MV*, Garcia-Morena D*, Iannone V*, El-Nezami H*, Kolehmainen M*, Kuipers OP* (2021). Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD. Tissue Barriers 19:1879719. DOI

Houttu V*, Boulund U*, Nicolaou M, Holleboom AG, Grefhorst A, Galenkamp H, van den Born B-J, Zwinderman K, Nieuwdorp M* (2021). Physical Activity and Dietary Composition Relate to Differences in Gut Microbial Patterns in a Multi-Ethnic Cohort—The HELIUS Study. Metabolites. 11(12):858. DOI

Houttu V*, Csader S*, Nieuwdorp M*, Holleboom AG, Schwab U* (2021). Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Frontiers in Nutrition 8:437. DOI

Zhang J, Ni Y, Qian L, Fang Q, Zheng T, Zhang, M, Gao Q, Zhang Y, Ni, J, Bao Y, Kovatcheva-Datchary P, Xu A, Li H, Panagiotou G*, Jia W (2021). Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Advanced Science 4:e2100536. DOI


Houttu V*, Boulund U*, Grefhorst A, Soeters MR, Pinto-Sietsma S-J, Nieuwdorp M* and Holleboom AG (2020). The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 13: 1-21 DOI


Zheng T, Li J, Ni Y, Kang K, Misiakou M-A, Imamovic L, Chow BKC, Rode AA, Bytzer P, Sommer M* and Panagiotou G*(2019). Mining, analyzing, and integrating viral signals from metagenomic data. Microbiome 7: 42 DOI

Liu Y, Wang Y, Ni Y, Cheung CKY, Lam KSL, Wang Y, Xia Z, Ye D, Guo J, Tse MA, Panagiotou G* and Xu A (2019). Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention. Cell Metab 31(1): 77-91 DOI

*BestTreat affiliated

Follow us